PPRUF Stock UPDATES Ppr Sa (PPRUF) 204.1580 08/28/2014 12:43

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ppr Sa (PPRUF) 204.1580 $PPRUF

Monthly Portfolio Data Now Available for Voya Closed-End Funds
PR Newswire - Wed Aug 20, 1:59PM CDT
Voya Investments, LLC today announced that monthly portfolio data as of July 31, 2014 is now available for the following closed-end management funds: Voya Asia Pacific High Dividend Equity Income Fund (NYSE: IAE), Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA), Voya Global Equity Dividend and Premium Opportunity Fund (NYSE: IGD), Voya International High Dividend Equity Income Fund (NYSE: IID), Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE), Voya Emerging Markets High Dividend Equity Fund (NYSE: IHD), Voya Natural Resources Equity Income Fund (NYSE: IRR) and Voya Prime Rate Trust (NYSE: PPR).

Paragon's Protect & Restore Backup Solution Safeguards Operations at Hit Radio Station Frequence Plus
M2 - Thu Aug 07, 3:02AM CDT
Maximum data security with central administration and low downtimes ensure business continuity. After thoroughly examining many different backup and disaster recovery solutions, the French regional broadcast station Frequence Plus opted for Paragon Protect & Restore (PPR) to safeguard its extensive IT infrastructure.

PPR - $.0280 July Dividend
Business Wire - Fri Aug 01, 12:55PM CDT
Voya Prime Rate Trust (NYSE: PPR) (formerly known as ING Prime Rate Trust), a diversified closed-end management investment company listed on the New York Stock Exchange, declared 2.80 cents per share monthly dividend on July 31, 2014 for the 31 days of July, payable on August 22, 2014 to shareholders of record on August 11, 2014. This represents the 315th consecutive monthly dividend since the Trust's inception in May 1988.

Voya Prime Rate Trust announces dividend of USD0.0280 per share
M2 - Fri Aug 01, 8:13AM CDT
A diversified, closed-end management investment company Voya Prime Rate Trust (NYSE PR) (CUSIP No 92913A 10 0) reported on Friday for July 2014, a dividend of USD0.0280 per share.

Voya Prime Rate Trust (NYSE: PPR) Dividend Declaration
Business Wire - Thu Jul 31, 2:00PM CDT
Voya Prime Rate Trust (NYSE: PPR):

Musicians Institute Changes the Way Musicians Learn with Music Prodigy
PRWeb - Tue Jul 15, 7:46AM CDT
Music Prodigy, creators of award-winning music education software that improves guitar and vocal performance with patented polyphonic pitch recognition (PPR™) technology, is proud to announce that Musicians Institute will be providing their guitar and vocal students with Music Prodigy's Rock Prodigy and Choir Prodigy software applications as part of their fall curriculum. Both will include Musicians Institute's unique and innovative training materials to help MI students improve their skills and accelerate their development.

Paragon Software Earns High Marks in TopTenReview's 2014 Ranking of Best Server Backup Software
PRWeb - Tue Jul 08, 7:17AM CDT
Paragon Software Group, a leader in data protection, backup and disaster recovery, today announced its Paragon Protect & Restore (PPR) image-based backup and disaster recovery (BDR) software has earned a 9.83 out of 10 points possible in TopTenReview's 2014 ranking of Best Server Backup Software. In addition, PPR tied with a leading global brand to capture the top spot in the professional support category, while also earning the highest possible ratings across three other server backup software categories including recovery and restoration, management tools and resource management.

China Animal Vaccine Industry Report, 2013-2016
M2 - Tue Jul 01, 8:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gdrhc6/china_animal) has announced the addition of the "China Animal Vaccine Industry Report, 2013-2016" report to their offering. In 2004-2013, Chinese animal vaccine market size maintained a high growth rate of 26.3%, reaching about RMB11.5 billion in 2013. The growth in 2007-2010 was mainly driven by the expansion of governmental tender vaccine, while that from 2011 was primarily thanks to the market-oriented vaccine expansion. The Chinese animal vaccine market is basically occupied by local companies, showing a self-sufficiency rate of around 90%. Given the policy factor, Chinese animal vaccine products are divided into compulsory immunization vaccines and market-oriented vaccines. At present, the former include foot-and-mouth disease (FMD), bird flu, porcine reproductive and respiratory syndrome (PRRS), swine fever, and peste des petits ruminants (PPR); the latter refer to porcine circovirus (PCV), Newcastle disease, porcine parvovirus (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with limited growth potential; however, market-oriented vaccines have developed faster, enjoying 40%-50% market share in 2013. As the scale of Chinese farming escalates, the demand for animal vaccines will continue to grow steadily. In the next few years, the Chinese animal vaccine industry is expected to keep a growth rate of approximately 15% and see market value of RMB17.5 billion or so in 2016. Key Topics Covered: 1. Overview of Animal Vaccine 2. Status Quo of Animal Vaccine Industry - Global Market - Chinese Market 3. Development Environment for China Animal Vaccine Industry - Major Policies - Tendering System for Compulsory Immunization Vaccine - Stable Development of Farming Industry - Large-scale Farming Becomes a Trend - Frequent Outbreaks of Animal Epidemics 4. Chinese Animal Vaccine Industry Segments - Governmental Mandatory Vaccine - FMD Vaccine - Bird Flu Vaccine - PRRS Vaccine - Swine Fever Vaccine - PCV Vaccine - Newcastle Disease Vaccine - Pet Vaccine 5. Key Enterprises - CAHIC - Jinyu Group - Tecon - Tech-bank - Shenghua Biok - Ringpu Bio-technology - Dahuanong - Hile Bio - Yikang - Chopper 6. Summary and Forecast - Swine Vaccine - Poultry Vaccine - Cattle and Sheep Vaccine - Pet Vaccine For more information visit http://www.researchandmarkets.com/research/gd...ina_animal

PPR - $.0315 March Dividend
Business Wire - Tue Apr 01, 2:24PM CDT
ING Prime Rate Trust (NYSE: PPR), a diversified closed-end management investment company listed on the New York Stock Exchange, declared 3.15 cents per share monthly dividend on March 31, 2014 for the 31 days of March, payable on April 22, 2014 to shareholders of record on April 10, 2014. This represents the 311th consecutive monthly dividend since the Trust's inception in May 1988.

ING Prime Rate Trust (NYSE: PPR) Dividend Declaration
Business Wire - Mon Mar 31, 2:04PM CDT
ING Prime Rate Trust (NYSE: PPR)

Houston Methodist Selects RightCare to Identify High-Risk Patients and Reduce Readmissions Among Mental Health Population
Business Wire - Tue Mar 11, 9:00AM CDT
RightCare announced today that Houston Methodist, one of the nation's leading hospital systems, will utilize RightCare's full software suite in three of their locations to identify high-risk patients for readmission among their mental health population. The locations include Texas Medical Center, San Jacinto/Baytown, and Willowbrook. This is a significant milestone for RightCare as it is their first application in the Texas market and a prestigious hospital system added to their growing roster.

PPR - $.0285 February Dividend
Business Wire - Mon Mar 03, 2:24PM CST
ING Prime Rate Trust (NYSE: PPR), a diversified closed-end management investment company listed on the New York Stock Exchange, declared 2.85 cents per share monthly dividend on February 28, 2014 for the 28 days of February, payable on March 24, 2014 to shareholders of record on March 10, 2014. This represents the 310th consecutive monthly dividend since the Trust's inception in May 1988.

Monthly Portfolio Data Now Available for ING Closed-End Funds
PR Newswire - Thu Feb 13, 11:44AM CST
ING Investments, LLC today announced that monthly portfolio data as of January 31, 2014 is now available for the following closed-end management funds: ING Asia Pacific High Dividend Equity Income Fund (NYSE: IAE), ING Global Advantage and Premium Opportunity Fund (NYSE: IGA), ING Global Equity Dividend and Premium Opportunity Fund (NYSE: IGD), ING International High Dividend Equity Income Fund (NYSE: IID), ING Infrastructure, Industrials and Materials Fund (NYSE: IDE), ING Emerging Markets High Dividend Equity Fund (NYSE: IHD), ING Risk Managed Natural Resources Fund (NYSE: IRR) and ING Prime Rate Trust (NYSE: PPR).

Infinera to Participate in Two Upcoming Investor Conferences
Marketwire - Tue Feb 04, 7:00AM CST
Infinera (NASDAQ: INFN), provider of Intelligent Transport Networks(TM), today announced that it will participate in the following webcasted investment community events:

ING Prime Rate Trust announces January dividend of USD0.0315 per share
M2 - Tue Feb 04, 6:25AM CST
US-based diversified closed-end management investment company, ING Prime Rate Trust (NYSE PR) released on Monday a monthly dividend of USD0.0315 per share, for the 31 days of January 2014.

PPR - $.0315 January Dividend
Business Wire - Mon Feb 03, 12:49PM CST
ING Prime Rate Trust (NYSE: PPR), a diversified closed-end management investment company listed on the New York Stock Exchange, declared 3.15 cents per share monthly dividend on January 31, 2014 for the 31 days of January, payable on February 25, 2014 to shareholders of record on February 10, 2014. This represents the 309th consecutive monthly dividend since the Trust's inception in May 1988.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 97

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 302

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 158

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Blend's AWS Financial Services Competency Enhances Innovations

Updated Category News Views 152

Blend Takes a Major Stride with AWS Financial Services Competency Exciting news emerges from Blend as the company secures a crucial recognition in the cloud technology arena. They've recently achieved the prestigious AWS Financial Services Competency badge, a testament to their outstanding expertise and remarkable track record in delivering innovative, secure, and...

Continue Reading
The Upcoming Surge of Last Mile Delivery Market Growth

Updated Category News Views 289

Overview of the Last Mile Delivery Market Growth The Last Mile Delivery market is poised for significant growth in the coming years, projected to rise by USD 51.1 billion from 2025 to 2029. This increase is primarily driven by the expanding global e-commerce sector and the integration of advanced technologies, including AI, which are transforming logistical operations....

Continue Reading
Tide Rock Expands Its Precision Machining Horizons Through Acquisitions

Updated Category News Views 326

Tide Rock Expands Its Precision Machining Horizons Tide Rock has taken a significant leap forward in the field of advanced precision machining through its recent acquisitions. By acquiring Precision Waterjet & Laser, now known as Precision Advanced Machining, located in Anaheim, California, and Made in America Manufacturing based in Buda, Texas, Tide Rock is enhancing its...

Continue Reading
Novavax Revises Projections, Anticipates Robust Nuvaxovid Demand

Updated Category News Views 149

Novavax Reports Strong Second Quarter Results Recently, Novavax Inc. reported impressive sales of $239.24 million for the second quarter of 2025, marking a significant shift from $415 million during the same period in the previous year. This figure exceeded the Wall Street consensus expectations, which estimated sales at $156.29 million. Such growth highlights Novavax's...

Continue Reading
Insights into Novartis' Cosentyx and GCAptAIN Study Findings

Updated Category News Views 219

Novartis' Groundbreaking Updates on Cosentyx in GCAptAIN Study Novartis has recently provided significant updates regarding the Phase III GCAptAIN study, focusing on the efficacy of Cosentyx (secukinumab) for patients suffering from giant cell arteritis (GCA). This condition, predominantly affecting older adults, poses a risk of severe complications if not managed...

Continue Reading